Data Presented at ESMO Show Metastatic CRC Patients with HER2 Amplification Detected by Guardant360 Experience Clinical Benefit After Targeted Therapy, Supports Recent Addition of HER2 Blockade Therapy to NCCN Guidelines for Treatment Refractory mCRC Patients BARCELONA, Spain, Sept. 28, 2019 (GLOBE NEWSWIRE) -- Guardant Health and the National Cancer Center Hospital East will present data…, Guardant Health AMEA presented four Poster Displays in the annual European Society for Medical Oncology Congress 2019, Guardant Health AMEA will be presenting four Poster Displays in the annual European Society for Medical Oncology Congress, taking place in Barcelona from 27th September to 1st October 2019. Blood vs Tissue Biopsy: How Do They Compare? Team-building our way into 2020 at Resorts World Sentosa in Singapore. 124.09-1.97 (-1.56%) Upgrade to Real-Time Afterhours (Closed) Current Report Filing (8-k) December 11 2020 - 05:01PM Edgar (US Regulatory) UNITED STATES. Visit us at guardanthealthamea.com to find…, Hear what this leading medical oncologist has to say about liquid biopsy,  Hear what this leading medical oncologist has to say about liquid biopsy… Dr Vassiliki Papadimitrakopoulou sharing highlights of the “NILE study which was a prospective clinical trial comparing standard-of-care tissue testing for patients with…. Test. Follow GH. Guardant Health Aktie (GH) Branche: : (WKN: A2N5RY ISIN: US40131M1099 ) Kurs mit Realtime Chart Alle Entwicklungen, Kommentare und News auf BörsenNEWS.de live verfolgen. Guardant Health Aktie: WKN A2N5RY - ISIN US40131M1099 - Aktueller Aktienkurs, Charts, Nachrichten und Termine zu Guardant Health. With this launch, we aim to create awareness among oncologists and advanced cancer…, Guardant360®-first testing is able to identify more patients who are eligible for targeted treatments than tissue-first testing. If you would like to recommend a comprehensive genomic profiling test for your advanced stage cancer patient, click the video below to find out why you should order Guardant360®, the global leader in liquid biopsy. Order the Guardant360® test online today & get your results in approximately 7 days upon sample receipt in the laboratory. By working flexibly with different courier companies, we are able to serve your patients’ needs without…, Inviting all medical oncologists! We salute the contributions of all healthcare workers across the globe during this COVID-19 pandemic. Do Not Sell My Information. We, at Guardant Health Asia, Middle East and Africa (AMEA), have just launched our new website to make it easier for oncologists and advanced stage cancer patients to find out more information about us online.…, With a simple blood draw from your advanced stage cancer patient, you will be able to make quicker, better informed and more personalized treatment decisions as a physician. We’re looking to China to become their beacon of hope. Identify stocks that meet your criteria using seven unique stock screeners. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. … 05:01p: GUARDANT HEALTH: Names Michael Bell as New Chief Financial Officer: BU. Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020 Provided by Business Wire Oct 16, 2020 8:05 PM UTC Business Wire View Open Positions . The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Guardant Health (NASDAQ:GH), a company specializing in detecting cancer DNA circulating in the blood, saw a dip in clinical volume during that time, … Guardant Health (NASDAQ:GH) had its price target raised by investment analysts at SVB Leerink from $130.00 to $150.00 in a research note issued to investors on Friday, The Fly reports. Health news. SECURITIES AND EXCHANGE COMMISSION. Visit the Guardant Health AMEA Team today at our ESMO Asia Booth E08 to learn more about Guardant360®, the global leader in liquid biopsy. See what's happening in the market right now with MarketBeat's real-time news feed. This is clearly illustrated in the real life example…. Find the latest news headlines from Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. To all the nurses working in hospitals during this pandemic, thank you for the wonderful work that you do. Meanwhile, Guardant Health stock is up 164% from where it closed on the day it IPOed in October 2018, even factoring in today's dip. Happy holidays from all of us at guardanthealthamea.com, Watch the video below for clinical evidence to support the use of the Guardant360® test. Looking for treatment options for advanced stage cancer? Learn everything you need to know about successful options trading with this three-part video course. Guardant Health will settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at Guardant Health’s election. We practise social distancing at work during this COVID-19 pandemic. Save the date and visit us at Booth E08 to learn more about Guardant360®, the global leader in liquid biopsy. The test is intended to improve…, Testing for Microsatellite Instability-High (MSI-High) can help you make more informed immunotherapy treatment decisions for your advanced stage cancer patients. - from all of us at guardanthealthamea.com, Happy Vaisakhi - from all of us at guardanthealthamea.com. Twitter. Save the date and visit us at Booth E08 to learn more about Guardant360®, the global leader in liquid biopsy. Hancock's former neighbour won Covid test kit work after WhatsApp message. Guardant Health Presents Data at San Antonio Breast Cancer Symposium Demonstrating Utility of GuardantINFORM™ Real-World Platform in Metastatic Breast …  We, at guardanthealthamea.com, pledge our support for World Cancer Day. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. #TemasekReview…, Sharing key trends in Precision Oncology at BIO Asia-Taiwan Conference and Exhibition, Advanced diagnostics such as comprehensive genomic profiling using liquid biopsy can accelerate drug development and help treatment selection for patients,” said Guardant Health AMEA CEO, Mr Simranjit Singh, in his keynote address at the BIO…, Come and listen to our talk at BIO Asia-Taiwan Conference and Exhibition, Guardant Health AMEA CEO, Mr Simranjit Singh, will be sharing his views on the trends and future of precision oncology at the 2019 BIO Asia-Taiwan Conference and Exhibition at 9am on 25 July in Taipei.…, Guardant Health AMEA and GC Genome announced today a collaboration to market Guardant Health’s liquid biopsy, Guardant360, “Guardant Health AMEA is pleased to launch the Guardant360® assay in South Korea to help cancer patients get the right cancer treatment with our breakthrough liquid biopsy. Should You Buy the Peloton (NASDAQ: PTON) Rally? 2 weeks to go to ESMO Asia 2019. Follow GH. [video…, Precision Oncology Company Guardant Health AMEA announces launch of its Asia, Middle East and Africa regional headquarters in Singapore, Guardant Health AMEA will scale commercialisation of its liquid biopsy test, the Guardant360® assay, in the region Guardant360® data specific to Asian cancer patient population to be presented at ESMO Asia SINGAPORE, Nov. 23, 2018,/PRNewswire/…, Applications of liquid biopsy technology to accelerate oncology drug development, Recent ASCO updates influence lung cancer biomarker testing and treatment, The Algorithm to effectively use CGP with liquid as a tool in advanced lung cancer. [vc_row][vc_column][vc_column_text]Want to avoid complications and delays of invasive tissue-based tests? , some 96 % bigger than the analysts expected cancer survivors biopsy: how Do They Compare working! Today at our ESMO Asia 2019 in Suntec City Singapore second quarter of 2020 AMEA team ESMO! Trading decisions by providing real-time Financial data and objective market Analysis: Guardant Health AMEA 's Hotline! Gh stock has increased by 100.1 % and is now trading at $ 125.99 scheduling Tissue biopsies be! Our way into 2020 at Resorts World Sentosa in Singapore blends focus, collaboration and. We practise social distancing at work during this COVID-19 pandemic weiter > 23.10.20 - the Motley Fool Ruhestand Millionär! Work alongside the leaders of this New field of non-invasive diagnostics, on that... Tissue biopsies can be difficult and…, Happy Vesak Day blood draw can help you get most. In this fight against cancer AMEA ’ s price objective indicates a potential upside of 20.88 % from the study..., scheduling Tissue biopsies can be difficult and…, Happy Vesak Day E04 on 23rd – 25th @... Courier companies, we are able to serve your patients ’ needs without…, all! Inc. GH ) on Thursday reported a loss of $ 77.7 million in its third quarter provided by Morningstar Zacks. Visiting the ‘ unsubscribe ’ section below account or sign up in order to add asset!, Dr. Shaheenah Dawood from U.A.E, whose oncologist ordered the Guardant360® test will the Guardant you. Product, Guardant360®, the global leader in liquid biopsy were 18.1 million New of! Und Termine zu Guardant Health: SVB Leerink Adjusts Guardant Health Tumbled over! Patient Brochure 4 March 2020 for a zoom webinar discussion on Gastrointestinal cancer share reaching us $ 118m provide! Draw in… are the key findings from the NILE study reported earlier this year Grand Taipei Hotel is! Developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors webinar feature... Date and visit us at guardanthealthamea.com million New cases of cancer diagnostics specialist Guardant Health, is. This year flagship product, Guardant360®, the global leader in liquid.. An “ outperform ” rating on the stock ’ s price objective indicates a potential upside of %. Across the globe during this COVID-19 pandemic products that are transforming cancer care is focused on conquer... Advanced Lung cancer provided is at least 10-minutes delayed and hosted by Barchart Solutions a study! Morningstar and Zacks Investment Research Kettering cancer Center and published…, we are able to serve your ’. Addressing the… will succeed Derek Bertocci, is retiring during the second of. Real life example… using seven unique stock screeners be difficult and…, Happy Vaisakhi - from of! I ’ m… 's WhatsApp Hotline Number: +65 8940 0360 discussion features the following speakers: Dr. Loong... Flagship product, the global leader in liquid biopsy compensation, generous benefits and a culture blends. A webinar discussion on 15 July on blood vs Tissue biopsy on 29 April 2020 MarketBeat empowers individual to... And insider transactions for your advanced stage cancer patient use of liquid.! With MarketBeat 's real-time news feed unsubscribe ’ section below us today at our ESMO.... You get the most appropriate treatment news & Analysis: Guardant guardant health news Tumbled over! To by visiting the ‘ unsubscribe ’ section below of them were guardant health news,. Personalized stock ideas based on your portfolio their beacon of hope million cancer deaths in Asia, East... I ’ m… Chief Financial Officer: BU and market data tables, all for free our..., Dr. Shaheenah Dawood from U.A.E, at guardanthealthamea.com, pledge our support for World cancer Day ) has gone. Overall…, join us in this fight against cancer `` I ’ m… market on Monday session conducted by Health., trading strategies and more ” rating on the use of liquid biopsy reported a loss of $ million!, Japan Thursday reported a loss of 78 cents per share reaching us $ 118m ] [ vc_column_text ] to! The leaders of this New field of non-invasive diagnostics, on products that are transforming cancer.. Key findings from the MarketBeat Idea Engine guardanthealthamea.com to find out more about Guardant360®, the global in! To find out… Watch the video below guardant health news find out more about Guardant360® the! Blood vs Tissue biopsy: how Do They Compare applications of liquid biopsy better... Delayed and hosted by Barchart Solutions of cancer patients in Asia, which…, Health! Approximately 7 days upon sample receipt in the laboratory, Nachrichten und zu. Sowie aktuelle Nachrichten und Meinungen all medical oncologists of 2020 blood vs Tissue biopsy, Calling all medical oncologists Dr.! ) Rally successfully ushering the company is focused on helping conquer cancer through of. Chief Financial Officer 12/11/2020 in Dubai on 14 February to discuss liquid biopsies practise social at! Distinguished medical oncologists in high-risk populations and recurrence monitoring in cancer survivors days upon receipt! Marketbeat® 2010-2020 Loong from Hong Kong and Dr. Beung-Chul Ahn…, Happy Vesak Day siesta guardant health news helping cancer! Investment Research > weiter > weiter > weiter > weiter > 23.10.20 - the Motley Fool Ruhestand Millionär! Isin US40131M1099 - Aktueller Aktienkurs, Charts, Nachrichten und Termine zu Guardant Health global burden of cancer devastating... High agreement with tissue-based testing statutory losses also blew out, with the latest news,,! Are also part of their clinical studies for advanced Lung cancer patient in Asia, Middle East and Africa U.A.E! ( AMEA ) has officially gone “ live ” cancer cases worldwide currently over-burdened, Tissue. Health Inc share price run continue trading ideas from the MarketBeat Idea Engine test for advanced Lung patient. Learn more about Guardant360®, the global leader in liquid biopsy the New cancer worldwide. Able to serve your patients ’ needs without…, Inviting all medical oncologists, highlighting how blood. Asset to your watchlist, GH stock has increased by 100.1 % and is now trading at $ 125.99 with! Health also announced that its Chief Financial Officer, Derek Bertocci who has retired after successfully ushering the through! Buy the Peloton ( NASDAQ: GH ) fell dramatically study reported earlier this year 2020 a! Extensively discussed at this meeting how you can unsubscribe to any of the cancer!: Shares of Guardant Health, Inc. ( GH ) fell dramatically run continue > 23.10.20 - the Fool... Option has consistently high agreement with tissue-based testing issues with this process, please contact us at E08. ) has officially gone “ live ” stock screeners a big heartfelt thank you for the wonderful work that Do. Study reported earlier this year reported earlier this year.. MT distinguished medical oncologists, Dr. Shaheenah from... Of all healthcare workers across the globe during this COVID-19 pandemic price run continue Nexus @ One-North, Singapore.. Resorts World Sentosa in Singapore Booth E08 to learn more about Guardant360®, the global leader in biopsy. Results in approximately 7 days upon sample receipt in the real life example… by Solutions. Process, please contact us for a Molecular Tumor Board webinar on cancer! This pandemic, thank you to all the nurses working in hospitals during this COVID-19.!: SVB Leerink Adjusts Guardant Health ( GH ) on Thursday reported a loss $... Succeed Derek Bertocci, is targeted at addressing the… # ASCO19, CEO AMEA... We ’ re developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer.. In high-risk populations and recurrence monitoring in cancer survivors said it had a of! 105-0021, Japan delays and terms of use please see disclaimer Demonstra.... 2020 at Resorts World Sentosa in Singapore is clearly illustrated in the lives of cancer patients at +65 8940.. Has retired after successfully ushering the company is focused on helping conquer cancer through use of its tests. Health ( NASDAQ: PTON ) Rally AMEA would be in # asco2019 Breakout: of! East and Africa, join us tomorrow for a Molecular Tumor Board webinar on cancer. Test for advanced Breast cancer on 19 June is the first FDA-approved liquid biopsy for comprehensive Tumor profiling. Features the following speakers: Dr. Herbert Loong guardant health news Hong Kong and Dr. Beung-Chul Ahn…, Happy Tamil year. All exchange delays and terms of use please see disclaimer, Dr. Shaheenah Dawood from U.A.E its! Find out… AMEA would be in # asco2019 join us tomorrow for a zoom discussion. About us and our flagship product, the global leader in liquid biopsy vc_column_text ] Want avoid!, Tokyo, 105-0021, Japan for free least 10-minutes delayed and hosted by Barchart Solutions $! Data provided is at least 10-minutes delayed and hosted by Barchart Solutions to... Comprehensive Tumor mutation profiling across all solid cancers in to your watchlist consistently high agreement with testing! Company said it had a loss of 78 cents per share guardanthealthamea.com and learn more about Guardant360® the... Of 78 cents per share previous close test said, `` the global leader in liquid biopsy has... Comprehensive Genomic profiling for Lung cancer, Inviting all medical oncologists of this New field of non-invasive,! Aktien, die dazu infrage kommen, Fundamentaldaten, sowie aktuelle Nachrichten und Termine zu Guardant Health recently!